San Diego, CA — Medvantx, a leading pharmacy services company, today announced that Kurt Browning has been named Chief Executive Officer. Outgoing CEO, Prasanna Parthasarathy will transition from his role and will continue to support the company as an advisor and investor.
Prasanna has played an important role in enhancing the business foundation and will remain a valued partner to the organization.
“Kurt has been deeply involved in the business and instrumental in strengthening our operating model over the past several years,” said Prasanna Parthasarathy. “He brings the right combination of operational expertise, financial discipline, and industry experience to lead Medvantx forward.”
Browning has strong executive experience across healthcare, specialty pharmacy, supply chain, and operations with a track record of execution in both public and private equity-backed organizations. He has held the CFO role at Medvantx for the past three years driving financial success for the organization. In parallel, he leads the transformation of core operational functions working closely with leaders to coordinate and reinforce execution, scalability, and cross-functional alignment.
Prior to Medvantx, Kurt established his depth of knowledge in healthcare, pharmacy services, and operations holding financial leadership roles at Synchrony Health Services, Onco360, and Quantix. At Onco360, he played a critical role in scaling the organization into one of the largest specialty pharmacies in the United States, supporting rapid growth while maintaining financial rigor. He also built a strong foundation in logistics and supply chain management at UPS Healthcare, where he supported complex, highly regulated supply chain solutions.
As CEO, Kurt will remain focused on operational excellence, regulatory rigor, and consistent execution in support of partners. He is well positioned to lead the next phase of growth as Medvantx expands capacity to service pharmacy, samples and healthcare distribution.
“The commitment to delivering high quality, compliant, and reliable solutions for our pharmaceutical partners and the patients they serve is the core of Medvantx,” said Browning. “I’m honored to have the opportunity to lead these great, hardworking teams, to advance our capabilities and meet the evolving needs of our customers.”
